These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36407860)

  • 21. First dose-ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy: Phase II investigator-initiated clinical trial.
    Ichijima R; Ikehara H; Maeda T; Sugita T; Horii T; Iwao A; Ogura K; Kusano C; Kondo Y; Suzuki T; Gotoda T
    Dig Endosc; 2022 Nov; 34(7):1403-1412. PubMed ID: 35612970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation.
    Zhou J; Curd L; Lohmer LRL; Delpratt N; Ossig J; Schippers F; Stoehr T; Schmith VD
    Clin Transl Sci; 2021 Jul; 14(4):1554-1565. PubMed ID: 33768731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.
    Rex DK; Bhandari R; Lorch DG; Meyers M; Schippers F; Bernstein D
    Dig Liver Dis; 2021 Jan; 53(1):94-101. PubMed ID: 33243567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.
    Dai G; Pei L; Duan F; Liao M; Zhang Y; Zhu M; Zhao Z; Zhang X
    Minerva Anestesiol; 2021 Oct; 87(10):1073-1079. PubMed ID: 34263581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study.
    Guo J; Qian Y; Zhang X; Han S; Shi Q; Xu J
    BMC Anesthesiol; 2022 Jun; 22(1):180. PubMed ID: 35689208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remimazolam: First Approval.
    Keam SJ
    Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remimazolam for anaesthesia or sedation.
    Sneyd JR; Rigby-Jones AE
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial.
    Chen SH; Yuan TM; Zhang J; Bai H; Tian M; Pan CX; Bao HG; Jin XJ; Ji FH; Zhong TD; Wang Q; Lv JR; Wang S; Li YJ; Yu YH; Luo AL; Li XK; Min S; Li L; Zou XH; Huang YG
    J Gastroenterol Hepatol; 2021 Feb; 36(2):474-481. PubMed ID: 32677707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Remimazolam for Procedural Sedation: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.
    Jhuang BJ; Yeh BH; Huang YT; Lai PC
    Front Med (Lausanne); 2021; 8():641866. PubMed ID: 34386505
    [No Abstract]   [Full Text] [Related]  

  • 34. Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation.
    Hu X; Tang Y; Fang X
    BMC Anesthesiol; 2023 Mar; 23(1):99. PubMed ID: 36991317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials.
    Dao VA; Schippers F; Stöhr T
    Endosc Int Open; 2022 Apr; 10(4):E378-E385. PubMed ID: 35433203
    [No Abstract]   [Full Text] [Related]  

  • 36. Remimazolam: A Novel Option for Procedural Sedation in High Risk Patients.
    Pantos MM; Kennedy DR; Nemec EC
    J Pharm Pract; 2023 Feb; 36(1):149-154. PubMed ID: 34155946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes.
    Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y
    Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparison of remimazolam and midazolam for the sedation of gastrointestinal endoscopy: a meta-analysis of randomized controlled studies.
    Zhang L; Li C; Zhao C; You Y; Xu J
    Afr Health Sci; 2022 Jun; 22(2):384-391. PubMed ID: 36407397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ; Yarmus LB; Schippers F; Ostroff R; Chen A; Akulian J; Wahidi M; Shojaee S; Tanner NT; Callahan SP; Feldman G; Lorch DG; Ndukwu I; Pritchett MA; Silvestri GA;
    Chest; 2019 Jan; 155(1):137-146. PubMed ID: 30292760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study.
    Park I; Cho M; Nam SW; Hwang JW; Do SH; Na HS
    BMC Anesthesiol; 2022 Jul; 22(1):237. PubMed ID: 35883039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.